5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 6.55▼ | 6.55▼ | 6.55▼ | 6.58▼ | 6.51▼ |
MA10 | 6.33▲ | 6.33▲ | 6.33▲ | 6.49▼ | 8.39▼ |
MA20 | 6.09▲ | 6.06▲ | 6.06▲ | 6.37▲ | 12.36▼ |
MA50 | 5.87▲ | 6.17▲ | 6.38▲ | 8.72▼ | 18.36▼ |
MA100 | 6.30▲ | 7.35▼ | 8.05▼ | 13.27▼ | 223.69▼ |
MA200 | 7.43▼ | 8.84▼ | 9.44▼ | 17.61▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.055▲ | 0.087▲ | 0.113▲ | 0.224▲ | 1.361▲ |
RSI | 56.382▲ | 54.231▲ | 52.436▲ | 42.365▼ | 31.954▼ |
STOCH | 71.528 | 71.528 | 71.528 | 58.837 | 8.162▼ |
WILL %R | -41.429 | -41.429 | -41.429 | -46.825 | -87.675▼ |
CCI | 42.675 | 42.675 | 42.675 | 20.355 | -100.157▼ |
Wednesday, April 30, 2025 05:01 AM
Quoin Pharmaceuticals (NASDAQ:QNRX) said it has received written notice from the Nasdaq stock market stating that the firm has regained compliance with the minimum bid price requirement. Press Release ...
|
Wednesday, April 30, 2025 04:30 AM
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a late clinical stage, specialty pharmaceutical company focused on the development and commercialization of therapeutic products ...
|
Wednesday, April 30, 2025 12:36 AM
ASHBURN, Va. - Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a specialty pharmaceutical company, announced today that it has regained compliance with Nasdaq’s minimum bid price requirement.
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
02/05/25 | 6.42 | 6.42 | 6.42 | 6.42 | 1,740 |
01/05/25 | 6.75 | 6.865 | 6.36 | 6.605 | 18,900 |
30/04/25 | 6.78 | 6.95 | 6.28 | 6.7685 | 48,102 |
29/04/25 | 6.695 | 6.695 | 6.50 | 6.50 | 91,043 |
28/04/25 | 7.2775 | 7.6616 | 6.60 | 6.60 | 27,923 |
25/04/25 | 6.82 | 7.53 | 6.79 | 7.1165 | 28,538 |
24/04/25 | 6.72 | 6.871 | 6.338 | 6.633 | 16,200 |
23/04/25 | 6.01 | 6.87 | 5.7799 | 6.56 | 38,121 |
22/04/25 | 5.85 | 6.23 | 5.49 | 6.00 | 39,335 |
21/04/25 | 5.29 | 6.235 | 5.27 | 5.67 | 79,500 |
|
|
||||
|
|
||||
|
|